Director Thomas T. Edman of TTM Technologies INC (NASDAQ:TTMI) executed a sale of 16,800 common shares on February 2, 2026, at $96.12 per share, producing proceeds of approximately $1.6 million. The transaction was carried out under an established 10b5-1 sales plan and was disclosed in a Form 4 filing with the Securities and Exchange Commission. After the disposition, Edman directly holds 783,406 shares of the company.
Following the February sale, TTM Technologies stock has advanced to $107.57, a gain of about 12% relative to the sale price, and is trading near its 52-week high of $111. The company has experienced a pronounced rally, delivering a 343% return over the past 12 months and a 140% increase in the last six months.
Despite recent market momentum, InvestingPro analysis cited in company coverage characterizes the stock as appearing overvalued at current levels. That assessment highlights valuation as a point of caution for investors assessing the recent gains.
On the business front, TTM Technologies announced a material multi-year agreement with Raytheon valued at approximately $200 million over three years. Under the arrangement, TTM will manufacture radio frequency assemblies and electronic components for Raytheon’s Lower Tier Air and Missile Defense Sensor program. The contract extends TTM’s existing contributions to the development and production-readiness activities associated with the LTAMDS program.
Analyst sentiment toward the shares has shifted alongside these developments. Truist Securities raised its price target on TTM to $113 from $91 while maintaining a Buy rating. The change in target followed comments from CEO Edwin Roks, who outlined expectations for annual growth of 15% to 20% over the coming years and stated plans to double earnings between 2025 and 2027. Those projections were highlighted during a recent investor conference.
Together, the insider transaction, the defense contract win, elevated analyst targets and management growth guidance frame a period of intense activity for TTM Technologies. The mix of strong historical returns, near-term contract revenue and forward-looking earnings goals is balanced by third-party analysis that flags valuation concerns.
Key takeaways:
- Director Thomas T. Edman sold 16,800 shares on Feb. 2, 2026, under a 10b5-1 plan for $96.12 per share; he now directly holds 783,406 shares.
- TTM stock has risen to $107.57 since the sale and is trading close to a 52-week high of $111 after a 343% one-year return.
- Company secured a roughly $200 million, three-year contract with Raytheon to produce RF assemblies and electronic components for the LTAMDS program; Truist raised its target to $113 from $91 and maintained a Buy rating following management guidance.
Contextual notes:
- Valuation concerns have been expressed by InvestingPro analysis despite the stock's strong performance.
- Management projects 15% to 20% annual growth and a plan to double earnings from 2025 to 2027, statements made at an investor conference and reflected in analyst commentary.